# A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis

> **NCT06860750** · PHASE3 · RECRUITING · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 380 (estimated)

## Conditions studied

- Active Non-radiographic Axial Spondyloarthritis

## Interventions

- **DRUG:** SHR-1314 Injection
- **DRUG:** SHR-1314 Placebo Injection

## Key facts

- **NCT ID:** NCT06860750
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-29
- **Primary completion:** 2028-02
- **Final completion:** 2028-12
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06860750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06860750, "A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06860750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*